MSAC [NASD]
Medicus Sciences Acquisition Corp.
Index- P/E42.10 EPS (ttm)0.23 Insider Own- Shs Outstand11.62M Perf Week0.35%
Market Cap113.99M Forward P/E- EPS next Y- Insider Trans- Shs Float9.38M Perf Month0.41%
Income2.70M PEG- EPS next Q- Inst Own- Short Float0.00% Perf Quarter0.62%
Sales- P/S- EPS this Y- Inst Trans-1.12% Short Ratio0.01 Perf Half Y0.72%
Book/sh7.54 P/B1.30 EPS next Y- ROA2.90% Target Price- Perf Year-
Cash/sh0.11 P/C87.69 EPS next 5Y- ROE3.20% 52W Range9.58 - 9.85 Perf YTD0.93%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-0.41% Beta-
Dividend %- Quick Ratio11.30 Sales past 5Y- Gross Margin- 52W Low2.40% ATR0.01
Employees- Current Ratio11.30 Sales Q/Q- Oper. Margin- RSI (14)60.70 Volatility0.05% 0.09%
OptionableNo Debt/Eq0.00 EPS Q/Q24.60% Profit Margin- Rel Volume0.16 Prev Close9.80
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume24.95K Price9.81
Recom- SMA200.29% SMA500.12% SMA2000.96% Volume4,036 Change0.15%
Aug-17-21 10:22AM  
Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.